NIBEC Co., Ltd. (KOSDAQ:138610)

Market Cap	286.03B
Revenue (ttm)	23.74B
Net Income (ttm)	-11.07B
Shares Out	11.31M
EPS (ttm)	-1,016.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	154,223
Average Volume	70,287
Open	24,500
Previous Close	24,650
Day's Range	24,500 - 26,200
52-Week Range	12,800 - 37,600
Beta	0.79
RSI	57.24
Earnings Date	Aug 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 96
• Stock Exchange: KOSDAQ
• Ticker Symbol: 138610

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.